InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,109.20
(
1.00%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
85.05
(
0.42%
)
Bitcoin
57,743.61
(
-0.48%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: rocky301 post# 42431

Wednesday, 03/28/2012 1:55:47 PM

Wednesday, March 28, 2012 1:55:47 PM

Post# of 92948
The Lanza interview was on Mar 23.

The 3rd SMD patient was treated on Mon Feb 6.

At 2:31 of the interview:

"And since the publication in the last few weeks back"

A few weeks back, at time of interview, would be end of Feb early Mar.

GR in his Blog on Feb 16 said:

"That being said, I am pleased to inform you that we are currently in the advanced stages of screening several more clinical trial candidates and are very confident that we will soon be able to treat two additional Dry AMD patients, rounding out the first cohort in the AMD trial."

I was hoping but definitely could be in error since there has been no PR.

Rocky301: Do you by chance have GR email address.

TIA





Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up